Literature DB >> 10987733

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.

C Fogarty1, R Goldschmidt, K Bush.   

Abstract

Three patients with bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae were treated unsuccessfully with azithromycin. One S. pneumoniae isolate carried a mef determinant for an efflux pump; a second isolate had an erm determinant. All 3 patients were successfully treated with levofloxacin, an antipneumococcal fluoroquinolone.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10987733     DOI： 10.1086/313976

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  25 in total

Review 1.  Role of beta-lactam agents in the treatment of community-acquired pneumonia.

Authors:  J Garau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

2.  Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia.

Authors:  Mark I Neuman; Meera Kelley; Marvin B Harper; Thomas M File; Carlos A Camargo
Journal:  J Emerg Med       Date:  2007-03-30       Impact factor: 1.484

3.  Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact?

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis       Date:  2002-01

Review 4.  Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Authors:  J D Fuller; A McGeer; D E Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

5.  Bacteremic pneumonia caused by extensively drug-resistant Streptococcus pneumoniae.

Authors:  Cheol-In Kang; Jin Yang Baek; Kyeongman Jeon; So Hyun Kim; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

Review 6.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  What Is the Clinical Impact of Macrolide Resistance?

Authors:  John R. Lonks
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

8.  Azithromycin use in paediatrics: A practical overview.

Authors:  Philippe Ovetchkine; Michael J Rieder
Journal:  Paediatr Child Health       Date:  2013-06       Impact factor: 2.253

9.  Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.

Authors:  Keith A Rodvold; Larry H Danziger; Mark H Gotfried
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 10.  International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.

Authors:  Thomas M File; James S Tan
Journal:  Drugs       Date:  2003       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.